Altum Sequencing

Startup Competition
Altum Sequencing is a biotech company enabling ultra-sensitive cancer monitoring from a simple blood draw. By combining deep DNA sequencing with advanced analytics, we detect minimal residual disease (MRD) and relapse risk earlier and more reliably than conventional follow-up alone, helping clinicians and trial teams make more confident decisions over time. Our differentiation is a scalable platform approach: we pair high-performance molecular testing with an AI-enabled data backbone, Altum Atlas, which standardizes interpretation, tracks patients longitudinally, and turns complex signals into clear, actionable insights. This combination supports repeatable monitoring programs and multi-site deployment, making precision oncology more practical for real-world healthcare and drug development.